About
Dr. Tan is the Chief Executive Officer at Nuevocor. Prior to that, he was the Chief Technologist and Company Founder of Atreca. He led the development of the technology underlying Atreca’s Immune Repertoire Capture™ platform while pursuing his dissertation research in William Robinson’s laboratory at Stanford University. He is the recipient of NSS(BS) and NSS(Ph.D.) fellowships from the Agency for Science, Technology, and Research (A*STAR) of Singapore. Dr. Tan received a BS in biology from Duke University and a Ph.D. in immunology from Stanford University.
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Yann Chong Tan is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Yann
Search Investors